These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9767753)

  • 21. Factors influencing outcome following the tension-free vaginal tape (TVT).
    Jha S; Jones G; Radley S; Farkas A
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):85-7. PubMed ID: 19261372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of utility measures for women with urge, stress, and mixed urinary incontinence.
    Harvie HS; Shea JA; Andy UU; Propert K; Schwartz JS; Arya LA
    Am J Obstet Gynecol; 2014 Jan; 210(1):85.e1-6. PubMed ID: 24055585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of coexistent stress and urge urinary incontinence.
    Karram MM; Bhatia NN
    Obstet Gynecol; 1989 Jan; 73(1):4-7. PubMed ID: 2909042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary incontinence in women.
    Wilkinson E
    Nurs Times; 2006 Nov 28-Dec 4; 102(48):23-4. PubMed ID: 17193773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.
    Cartwright R; Srikrishna S; Cardozo L; Robinson D
    BJU Int; 2011 Jan; 107(1):70-6. PubMed ID: 20626389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
    Malone-Lee J; Shaffu B; Anand C; Powell C
    J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies.
    MacDiarmid SA; Anderson RU; Armstrong RB; Dmochowski RR
    J Urol; 2005 Oct; 174(4 Pt 1):1301-5; discussion 1305. PubMed ID: 16145407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary incontinence among adult women with diabetes in Jordan: epidemiology, correlates and perceived impact on emotional and social well-being.
    Bani-Issa W; Almomani F; Eldeirawi K
    J Clin Nurs; 2014 Sep; 23(17-18):2451-60. PubMed ID: 24112089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Terodiline in the treatment of stress incontinence in women].
    Feyereisl J; Hänggi W; Dreher E
    Schweiz Rundsch Med Prax; 1990 Apr; 79(14):420-2. PubMed ID: 2343228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.
    Sand PK; Davila GW; Lucente VR; Thomas H; Caramelli KE; Hoel G
    Am J Obstet Gynecol; 2012 Feb; 206(2):168.e1-6. PubMed ID: 21963104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome.
    Sammour ZM; Gomes CM; de Bessa J; Pinheiro MS; Kim CA; Honjo RS; Trigo-Rocha FE; Bruschini H; Srougi M
    J Urol; 2012 Jul; 188(1):253-7. PubMed ID: 22595063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of oxybutynine chloride in children.
    Autret E; Jonville AP; Dutertre JP; Bertiere MC; Robert M; Averous M; Couet W
    Eur J Clin Pharmacol; 1994; 46(1):83-5. PubMed ID: 8005192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.
    Burgio KL; Goode PS; Richter HE; Markland AD; Johnson TM; Redden DT
    J Urol; 2010 Aug; 184(2):598-603. PubMed ID: 20639023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of single vaginal incision technique on quality of life in women with stress urinary incontinence.
    Karateke A; Cam C; Ince SB; Tug N; Selcuk S; Asoglu MR; Vatansever D
    J Minim Invasive Gynecol; 2011; 18(5):634-9. PubMed ID: 21872169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of the use of oxybutynin hydrochloride (Pollakisu tablets) in the elderly].
    Uchibayashi T; Nakajima K; Nihino A; Hisazumi H
    Hinyokika Kiyo; 1991 Sep; 37(9):1077-85. PubMed ID: 1785418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadaveric prolapse repair with sling: intermediate outcomes with 6 months to 5 years of followup.
    Frederick RW; Leach GE
    J Urol; 2005 Apr; 173(4):1229-33. PubMed ID: 15758758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.